208eP Triple-targeted therapy with encorafenib, binimetinib and osimertinib in BRAF- and EGFR-co-mutated non-small cell lung cancer: A single-center experience

20260 citationsJournal Articlegold Open Access

Authors

Good health and well-being

Published in: ESMO Open

Volume 11, pp. 106515-106515

Field-Weighted Citation Impact: 0.00